Ousted vaccine panel members say rigorous science is being abandoned Seventeen experts ousted from a U.S. vaccine committee are expressing little faith in what the panel has become The Independent UK · Jul 30, 2025
Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure. International Business Times UK · Jul 30, 2025
Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks. Benzinga · Jul 30, 2025
'Universal' cancer vaccine heading to human trials could be useful for 'all forms of cancer' A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials. LiveScience · Jul 30, 2025
FDA’s top vaccine official leaves post after less than four months Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions The Guardian - US · Jul 30, 2025
GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 guidance. Benzinga · Jul 30, 2025
US medical groups fill gap with own vaccine guides amid ‘information crisis’ As official health guidance changes, scientific groups are stepping in with evidence-based recommendations The Guardian - US · Jul 30, 2025
1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again. Barchart · Jul 29, 2025
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption' Health and Human Services Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program, describing the system as fundamentally broken and failing its intended purpose. Benzinga · Jul 29, 2025
RFK Jr. sets out to ‘discover’ what causes autism by September, and vaccine lawyers could get very rich from the results Discover by autumn, sue by winter. We Got This Covered · Jul 28, 2025
RFK Jr. looks to boot panel that decides which HIV and cancer screenings will be free: report Decisions from the U.S. Preventative Services Task Force impact millions of people’s access to preventative care for cancer, infectious diseases and mental health The Independent UK · Jul 26, 2025
Scientists gave mice flu vaccines by flossing their tiny teeth — and it worked In a proof-of-concept study, scientists have shown that flossing your teeth could be a way to deliver vaccinations that protect you against viruses. LiveScience · Jul 25, 2025
Parents seeking religious exemptions to school vaccines win reprieve in a West Virginia county A West Virginia judge has allowed children from three families to attend school without required vaccinations The Independent UK · Jul 24, 2025
Vaccine-Skeptic RFK Jr. Finalizes Ban On Mercury-Based Thimerosal In US Flu Vaccines U.S. Health and Human Services Secretary Robert F. Kennedy Jr. approved a major policy change on Tuesday that will remove the mercury-based preservative thimerosal from all flu vaccines distributed in the U.S. Benzinga · Jul 24, 2025
Benzinga · Jul 24, 2025 Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates Novavax, Inc. (NASDAQ:NVAX) on Thursday revealed preclinical data from the H5N1 avian pandemic influenza vaccine candidate.
Benzinga · Jul 23, 2025 What's Going On With Moderna Stock Wednesday? Moderna Inc.’s (NASDAQ:MRNA) stock has surged approximately 37% in the last month but has dipped around 15% year to date.
The Guardian - US · Jul 23, 2025 RFK Jr to remove preservative thimerosal from all US vaccines Anti-vaccine campaigns have targeted thimerosal for decades despite no evidence of ingredient causing harm
Roll Call · Jul 23, 2025 Kennedy adopts panel's advice to remove flu shot ingredient - Roll Call Vaccine makers removed thimerosal from roughly 95 percent of flu vaccinations in 1999 following unfounded claims about mercury.
The Guardian - UK · Jul 23, 2025 Look at the rise of measles in England and ask yourself: have we learned a single thing from Covid? People grow complacent about vaccines precisely because they are so effective. What happened to collective responsibility, asks Guardian columnist Frances Ryan
Benzinga · Jul 22, 2025 Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in London, U.K.
The Guardian - UK · Jul 22, 2025 Make Lime bikes free for teenagers Brief letters: Incentives for good behaviour | Writing to royals | Sterilising light switches | ‘Vaccine hesitancy’ | Always against genocide
The Conversation · Jul 22, 2025 How falling vaccination rates are fuelling the antibiotic resistance crisis Antibiotic resistance is one of the biggest health threats we face today. It’s often blamed on the overuse of antibiotics, and for a good reason. But there’s another major factor quietly driving this crisis that doesn’t get as much attention: low vaccination rates.
Kids Ain't Cheap · Jul 22, 2025 Think Again: 5 Vaccinations Parents Are Skipping Putting Kids At Risk Image source: 123rf.com
Euronews · Jul 22, 2025 Billion euro deal: Sanofi buys UK biotech company to expand respiratory vaccine portfolio French pharmaceutical company Sanofi said it is acquiring London-based Vicebio to expand its range of respiratory virus vaccines and add a non-mRNA vaccine to its pipeline.
The Conversation · Jul 22, 2025 COVID, flu, RSV: how these common viruses are tracking this winter – and how to protect yourself Winter is here, and with it come higher rates of respiratory illnesses. If you’ve been struck down recently with a sore throat, runny nose and a cough, or perhaps even a fever, you’re not alone.